Martin Hoenigl
Tenure Track Prof for Translational Mycology, Medical University Graz, Austria; Past President ECMM.❤️for Clinical Mycology, ⬛⬜1909 ⚽️ Rams 🏈#StandwithUkraine
- Reposted by Martin HoeniglUpcoming @idsainfo.bsky.social Immunocompromised Host COP and @msgerc.bsky.social webinar: Feb 10, 2026 10:00 AM Central "Testing Rationally in Mycology: Using Fungal Diagnostics to Drive Better Antifungal Decisions" Sign up here: societycentral.zoom.us/webinar/regi...
- Reposted by Martin HoeniglNew webinar on fungal diagnostics! Link in next post
- Reposted by Martin HoeniglUpdate on Candida IV study at #TIMM2025 Still open for registration 🔬🧫🧪 Join now!
- Reposted by Martin HoeniglEarly mycological clearance in uncomplicated candidaemia can improve outcomes, reduce ICU stay, and lower healthcare costs. Timely antifungal therapy is key. Read more: doi.org/10.1111/myc.... @martinhoenigl.bsky.social #Candidaemia #AntifungalTherapy #InfectiousDiseases #ICU #Healthcare
- Reposted by Martin Hoenigl2025 #Candida #Guidelines by ECMM, ISHAM, ASM + Summary recs here; full evidence, methods + pediatric guidance in appendix. www.thelancet.com/journals/lan... @olivercornely.bsky.social @martinhoenigl.bsky.social @anaalastruey.bsky.social @germhuntermd.bsky.social @fhagen.bsky.social
- Reposted by Martin HoeniglGALActIC Project – EU Collaboration Against IAPA | Consortium Meeting on Future Planning in Bilbao 🇪🇸 Galactic Europe: lnkd.in/d77xessA @martinhoenigl.bsky.social @simonfeys.bsky.social @agocarvalho.bsky.social
- Reposted by Martin Hoenigl✨📄 What about the untapped therapeutic potential of the immune response in invasive aspergillosis ? Here’s some rational, pre-clinical and clinical evidence. Huge thanks to our amazing 🌍 team! 🔗 bit.ly/46kajHr @simonfeys.bsky.social @agocarvalho.bsky.social @martinhoenigl.bsky.social
- 🔥🗞️Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b study. Groundbreaking work on a very promising new antifungal. Free access here: authors.elsevier.com/c/1lHca5E-Uo...
- Reposted by Martin Hoenigl🚨Our latest review in Thorax about the impact of climate change focusing on fungal pathogens in Europe 🌍 A truly enjoyable collaboration with Sarah Sedik @germhuntermd.bsky.social @martinhoenigl.bsky.social and @mbottery.bsky.social thorax.bmj.com/content/earl...
- Reposted by Martin HoeniglAddressing Antifungal Drug Resistance — A “One Health–One World” Challenge @grthompsonmd.bsky.social and Angel Desai www.nejm.org/doi/full/10....
- Reposted by Martin HoeniglClimate change: shifting boundaries of fungal disease in Europe and beyond New review in Thorax by @mbottery.bsky.social Sarah Sedik @germhuntermd.bsky.social @martinhoenigl.bsky.social @normanvanrhijn.bsky.social thorax.bmj.com/content/thor... #MedSky #IDSky #PulmSky #ClimateSky #MedMycoSky
- Reposted by Martin HoeniglDiagnosis and Management of Candida Endophthalmitis and Chorioretinitis Nate Permpalung, Sarah Sedik, Pete Pappas, @martinhoenigl.bsky.social, @drluiso.bsky.social in @cmijournal.bsky.social www.clinicalmicrobiologyandinfection.com/article/S119...
- Reposted by Martin HoeniglProud to present the progress of ECMM Candida IV study at #ISHAM2025 Still open for participation! @martinhoenigl.bsky.social
- Reposted by Martin HoeniglYesterday at ISHAM 2025, Danila Seidel explored how environmental extremes can spark fungal outbreaks 🌪️🌱 A powerful reminder of climate’s role in emerging mycoses. #ISHAM2025 #FungalOutbreaks #ClimateAndHealth #MedicalMycology
- Reposted by Martin HoeniglDid you know..75% of wine has significant levels of azole antifungals in it? (German wine anyway) Potential consequences for driving resistance... #IDSky #ISHAM
- Reposted by Martin HoeniglHappy to meet some wonderful colleagues & brilliant minds in Medical Mycology. @martinhoenigl.bsky.social @germhuntermd.bsky.social at #ISHAM2025 It has been an amazing congress with enriching academic sessions, lovely food & great hospitality at such a captivating location @fozdoiguacu.bsky.social
- Reposted by Martin HoeniglThrilled to see Dr. Jon Salmanton-García receive the GEMICOMED Young Researcher Award 2025! His impactful research on invasive fungal & viral infections in hematologic malignancies is shaping the future of mycology: www.journalofinfection.com/article/S016... #FungalResearch #Mycology
- Reposted by Martin HoeniglExciting news! The ECMM Candida IV study is now featured on the ECMM website! Find all the details here: www.ecmm.info/working-grou... @martinhoenigl.bsky.social
- Sampling different types of grains at local markets in Namibia starting our project Fungal diversity of processed staple cereals from rural subsistence farming communities in Namibia 🙏🏻🙏🏻to colleagues from University of Namibia for hosting me
- Reposted by Martin HoeniglHonored to present today at ESCMID Global in Vienna: Ibrexafungerp salvage results from 233 patients in the FURI study — showing high success rates! 🔬💪 A promising new tool in the antifungal pipeline. #ESCMID2025 #FURIstudy #Ibrexafungerp #Antifungals #InfectiousDiseases
- Reposted by Martin HoeniglECMM Candida IV Study is still open for participation Global study on non-albicans candidemia Requirements: 🔬Clinical data + isolates (no limit per site) 📅Apr 2024-Sep 2025 📦Ship isolates in one batch at study end 💰Case-based reimbursement available @martinhoenigl.bsky.social
- 👉Participate in the ECMM Candida IV Study 🌍wide study on candidemia caused by non-albicans Candida Requirement: clinical data & isolate (not req for C.auris) Observation period: 04/2024 - 09/2025 Interested? Email stella.wolfgruber@medunigraz.at
- Reposted by Martin HoeniglOn April 1, 2025, our project officially started. A significant milestone that we have worked towards for a long time. Now, we look forward to taking the next steps together. @martinhoenigl.bsky.social @simonfeys.bsky.social @agocarvalho.bsky.social
- Projekt „GALActIC“ startet: Biomarker für Pilzinfektionen erforscht www.medunigraz.at/news/detail/...
- Reposted by Martin Hoenigl🔬💡 ICVS Researchers Join Innovative GALActIC Study to Combat IAPA! Researchers of the I3D team are part of this European project, aiming to improve the identification and treatment of Influenza-associated Pulmonary Aspergillosis and enhance patient care! 🙌 More at: icvs.uminho.pt/icvs-researc...
- Reposted by Martin HoeniglA potentially new antifungal class: Mandimycin, polyene-like but targeting phospholipids, rather than ergosterol. ✅activity against yeasts in vivo 🐁 With insights from @olivercornely.bsky.social @martinhoenigl.bsky.social & David Denning www.science.org/content/arti...
- Deadly fungi are becoming drug-resistant. A new compound could beat them | Science | AAAS @kakape.bsky.social www.science.org/content/arti...
- Reposted by Martin Hoenigl🔬 New research highlights a potential game-changer in treating invasive mould infections! 🦠 Patients show increased PD-1 expression, suggesting immune checkpoint inhibitors could help fight these deadly infections. More studies needed! 💡 onlinelibrary.wiley.com/doi/10.1111/... #Immunotherapy
- Reposted by Martin HoeniglNew Medical Study Starting Soon 🔬 The logo was designed in collaboration with Galactic Partners, with professional support from Esra Sedik. Follow us for more! @martinhoenigl.bsky.social @agocarvalho.bsky.social @simonfeys.bsky.social
- Reposted by Martin HoeniglAre contemporary antifungal doses sufficient for critically ill patients? Outcomes from an international, multicenter PK study for Screening Antifungal Exposure in Intensive Care Units (SAFE-ICU) J Roberts etc TLDR: ++variable, need tailored approach w TDM link.springer.com/article/10.1...
- Reposted by Martin Hoenigl🌍 Fungal Care Gaps: Brazil vs. Europe 🇧🇷➡️🇪🇺 Fungal infections are a global challenge with uneven access to diagnostic and treatment. Europe has more labs, better tests, and antifungal access, while Brazil faces greater threats from Cryptococcus and Histoplasma. journals.asm.org/doi/epub/10....
- Reposted by Martin HoeniglIt’s out! A pleasure to work with @alukmd.bsky.social on the latest #fungal update of the ID Clinics of North America. I rembember saving money as a med student to buy them… #FullCircle #IDSky #MedSky
- Reposted by Martin HoeniglPrevalence of injecting-related bacterial and fungal infection among people who inject drugs: a systematic review and meta-analysis ✅ Just Accepted #IDSky
- Reposted by Martin HoeniglDespite being vastly outnumbered by bacteria, fungi in our microbiome still play a significant role in our health. In today’s episode, we learn about the “mycobiome.” Plus, turmoil at the NIH. Listen here 🎧: buff.ly/4ii9d2g
- Reposted by Martin Hoenigl[This post could not be retrieved]
- Antifungal pipeline: New tools for the treatment of mycoses. Focus on LMICs where many dont have access to current antifungals. Updated maps on fungal availability in LMICS. Thanks to a fantastic group of authors www.sciencedirect.com/science/arti...
- Reposted by Martin HoeniglFungal Infections in People Who Use Drugs Jose Portugal Gonzales & @drluiso.bsky.social academic.oup.com/ofid/advance...
- Reposted by Martin Hoenigl📢 New article! 🦠 Insights on tackling Candida infections, rising antifungal resistance, and evolving treatment strategies. Immediate action is key! Read more: www.contagionlive.com/view/address... #Candida #InfectiousDiseases #AntifungalResistance
- Reposted by Martin HoeniglNew guidelines for diagnosis and management of candidiasis from ECMM in cooperation with @ishamycology.bsky.social and @asm.org Led by @olivercornely.bsky.social & @rosannesprute.bsky.social with contributions from >100 experts Reposting with algorithms 🔓🔗: authors.elsevier.com/sd/article/S...
- Reposted by Martin HoeniglRamage et al. (2025) discuss fungal biofilms' rising clinical impact, highlighting their resistance to treatment and need for new strategies like novel antifungals, nanotech, and biofilm-disrupting agents.
- Reposted by Martin HoeniglIt’s here! Truly epic work from the @unicologne.bsky.social team! Honored to have been part of this project.
- Reposted by Martin HoeniglNew guidelines for diagnosis and management of candidiasis from ECMM in cooperation with @ishamycology.bsky.social and @asm.org Led by @olivercornely.bsky.social @rosannesprute.bsky.social with contributions from >100 experts Author link: authors.elsevier.com/sd/article/S... #IDSky
- Global guideline for the diagnosis and management of candidiasis: ECMM @youngecmm.bsky.social in cooperation with @ishamycology.bsky.social & ASM. Big congrats to @olivercornely.bsky.social & @rosannesprute.bsky.social for leading this tremendous team www.sciencedirect.com/science/arti...
- Reposted by Martin HoeniglSuper happy to be part of this team investigating genetics in influenza-associated aspergillosis! Now we just need a logo…
- Kickoff meeting for the 🌌Galectin-3 targeted antifungal prophylaxis in ICU influenza (GALActIC)🌌 eppermed.eu project at UZLeuven Incredibly productive meeting with the Galactic team @agocarvalho.bsky.social @simonfeys.bsky.social @msgerc.bsky.social @ishamycology.bsky.social
- Reposted by Martin HoeniglWould global warming bring an increase of invertebrate-associated cutaneous invasive fungal infections? Kontoyiannis & Casadevall journals.asm.org/doi/10.1128/...
- Reposted by Martin HoeniglWarmer climates could supercharge fungal diseases transmitted by insects. pubmed.ncbi.nlm.nih.gov/39907444/
- Kickoff meeting for the 🌌Galectin-3 targeted antifungal prophylaxis in ICU influenza (GALActIC)🌌 eppermed.eu project at UZLeuven Incredibly productive meeting with the Galactic team @agocarvalho.bsky.social @simonfeys.bsky.social @msgerc.bsky.social @ishamycology.bsky.social
- Reposted by Martin HoeniglPulmonary Co-Infection of Pneumocystis jirovecii and Aspergillus species Hatzl and colleagues in @ofidjournal.bsky.social academic.oup.com/ofid/advance...
- Reposted by Martin HoeniglNice overview of the problems we face when tackling fungal infections and how climate change might exacerbate them. With quotes from myself and @martinhoenigl.bsky.social #immunosky #microsky 🧪 www.dailymail.co.uk/sciencetech/...
- Posaconazole for Prevention of COVID-19-Associated Pulmonary Aspergillosis in Mechanically Ventilated Patients: A European Multicentre Case–Control Study (POSACOVID) onlinelibrary.wiley.com/doi/full/10....
- Reposted by Martin HoeniglWhen you think of Aspergillus, you think of potentially-fatal disease in SCT or CGD patients. This Aspergillus may be going for the ovaries 😳 Aspergillus tubingensis in patients with polycystic ovary syndrome (PCOS) & mice with PCOS-like disorder www.cell.com/cell-host-mi...
- Reposted by Martin HoeniglEmerging #Sporothrix brasiliensis is fueling a cat-transmitted sporotrichosis #outbreak in Northeast Brazil. Over 1,100 cases identified in Recife's metro region (2016-2021), with zoonotic transmission linked to Rio de Janeiro strains. Link: link.springer.com/article/10.1... #PublicHealth #Zoonoses
- Reposted by Martin HoeniglPredictors of Cryptococcus gattii clinical presentation and outcome: An international study doi.org/10.1093/cid/...
- Advancing Patient Advocacy in Mycology: Cultivating Collaboration in Education, Research, and Policy @springernature.bsky.social #Mycopathologia link.springer.com/content/pdf/...
- Reposted by Martin HoeniglPerformance of diagnostic algorithms in patients with invasive pulmonary aspergillosis Stefan Hatzl, et al. Clinical Infectious Diseases, ciae633, doi.org/10.1093/cid/...
- Reposted by Martin HoeniglComparative efficacy and safety of treatment regimens for Pneumocystis jirovecii pneumonia in people living with HIV – A systematic review and network meta-analysis of randomized controlled trials Hatzl et al TLDR: “no clear best choice” www.clinicalmicrobiologyandinfection.com/article/S119...
- Reposted by Martin HoeniglLooking for medical mycology content? Check out accounts in the Medical Mycology starter pack: go.bsky.app/8XGywEx and check out (and pin) the new MycoSky feed for all things medical mycology bsky.app/profile/did:...
- 📰Review on "Climate Change and Medical Mycology" Congrats to Sarah Sedik and Matthias Egger for great figures, tables and content! 🙏to @drluiso.bsky.social for the invite Full access here authors.elsevier.com/a/1kHp73AjoX...
- 📰Review on "Climate Change and Medical Mycology" Congrats to Sarah Sedik and Matthias Egger for great figures, tables and content! 🙏to @drluiso.bsky.social for the invite Full access here authors.elsevier.com/a/1kHp73AjoX...
- Reposted by Martin HoeniglIn a linked podcast, Rebecca Barksby of The Lancet Microbe speaks to Professor Martin Hoenigl about the impact of #ClimateChange and natural disasters on fungal diseases. thelancetmicrobe.buzzsprout.com/1794195/1477... #Fungi #MycoSky #MicroSky
- Reposted by Martin HoeniglVery excited about this lecture at the ECMM symposium #InFocus2024
- Reposted by Martin Hoenigl🆕 Few thoughts we wanted to share with the community to look at 🍄 #aspergillosis diagnosis from a different perspective when we are still struggling on the topic. w/ @simonfeys.bsky.social @agocarvalho.bsky.social & cie Actively working on more answers. Stay tuned. 👉 doi.org/10.1016/j.cm...
